The glycoprotein V of the blood platelets is an important switch point for haemostasis and thrombus formation. This new finding could have great clinical potential. When our blood vessels are injured ...

Researchers who identified a novel mechanism for platelet activation in pathogenic blood clotting (thrombosis) are now turning their attention to sepsis. Researchers from the University of Birmingham, ...

In recent years, scientists have begun to explore another potential contributor: blood type. A study published in Journal of ...

Blood clot researchers could benefit from a new device that mimics a human vein, replacing the need for animals for some studies. The vein-on-a-chip model has been developed by scientists at the ...

In my last article, I described a situation when we had to struggle to get a blood thinning medicine to a patient with a blood clot. Today, I will try to explain how blood clots form in the body and ...

Winter can quietly change blood flow, making it thicker and more prone to clotting. Doctors explain the science and simple ...

Blood is a remarkable material: it must remain fluid inside blood vessels, yet clot as quickly as possible outside them, to stop bleeding. The chemical cascade that makes this possible is well ...

Every year, millions of people develop dangerous blood clots in their legs without realizing the life-threatening risk growing within their bodies. These formations, medically known as deep vein ...

Lecanemab (Lequembi, Esai), an amyloid beta–directed antibody therapy, is approved by the US Food and Drug Administration (FDA) for the treatment of Alzheimer's disease (AD). But exactly how the drug ...

When our blood vessels are injured by cuts, abrasions, or bruises, it is vital that the bleeding is stopped, and the wound is sealed. This process is called hemostasis and involves two main components ...